- General Oncology
  - Cancer Biology
    - [Introduction](general-oncology/cancer-biology/Introduction)
    - [Hallmarks of Cancer](general-oncology/cancer-biology/Hallmarks-of-Cancer)
    - [Oncogenes and Tumor Suppressors](general-oncology/cancer-biology/Oncogenes-and-Tumor-Suppressors)
    - [Genomic Instability and DNA Repair Mechanisms](general-oncology/cancer-biology/Genomic-Instability-and-DNA-Repair-Mechanisms)
    - [Epigenetics in Cancer](general-oncology/cancer-biology/Epigenetics-in-Cancer)
    - [Tumor Microenvironment (TME)](general-oncology/cancer-biology/Tumor-Microenvironment)
    - [Clonal Evolution and Tumor Heterogeneity](general-oncology/cancer-biology/Clonal-Evolution-and-Tumor-Heterogeneity)
    - [Cancer Stem Cells (CSCs)](general-oncology/cancer-biology/Cancer-Stem-Cells)
    - [Angiogenesis in Tumors](general-oncology/cancer-biology/Angiogenesis-in-Tumors)
    - [Invasion and Metastasis](general-oncology/cancer-biology/Invasion-and-Metastasis)
    - [Cancer Metabolism](general-oncology/cancer-biology/Cancer-Metabolism)
    - [Viral Oncogenesis](general-oncology/cancer-biology/Viral-Oncogenesis)
    - [Tumor Immune Evasion and Immunoediting](general-oncology/cancer-biology/Tumor-Immune-Evasion-and-Immunoediting)
    - [Mechanisms of Resistance to Therapy](general-oncology/cancer-biology/Mechanisms-of-Resistance-to-Therapy)
    - [Case-Based Applications](general-oncology/cancer-biology/Case-Based-Applications)
    - [Clinical Application Summary](general-oncology/cancer-biology/Clinical-Application-Summary)
    - [Landmark Trials and References](general-oncology/cancer-biology/Landmark-Trials-and-References)
  - Performance Status
    - [Introduction](general-oncology/performance-status/Introduction)
    - [ECOG Performance Status (WHO Scale)](general-oncology/performance-status/ECOG-Performance-Status)
    - [Karnofsky Performance Status (KPS)](general-oncology/performance-status/Karnofsky-Performance-Status)
    - [Frailty Assessment and Geriatric Oncology Tools](general-oncology/performance-status/Frailty-Assessment-and-Geriatric-Oncology-Tools)
    - [Performance Status in Treatment Planning](general-oncology/performance-status/Performance-Status-in-Treatment-Planning)
    - [Performance Status in Clinical Trials](general-oncology/performance-status/Performance-Status-in-Clinical-Trials)
    - [Performance Status in Special Populations (Pediatric, Elderly)](general-oncology/performance-status/Performance-Status-in-Special-Populations)
    - [Summary Table](general-oncology/performance-status/Summary-Table)
    - [Key Takeaways](general-oncology/performance-status/Key-Takeaways)
    - [Clinical Pearls](general-oncology/performance-status/Clinical-Pearls)
  - Prognostic Scores
    - [Introduction](general-oncology/prognostic-scores/Introduction)
    - [Key Prognostic Score Types](general-oncology/prognostic-scores/Key-Prognostic-Score-Types)
    - [International Prognostic Index (IPI) – NHL](general-oncology/prognostic-scores/International-Prognostic-Index)
    - [FLIPI – Follicular Lymphoma](general-oncology/prognostic-scores/FLIPI-Follicular-Lymphoma)
    - [R-ISS – Multiple Myeloma](general-oncology/prognostic-scores/R-ISS-Multiple-Myeloma)
    - [IPSS – Myelodysplastic Syndromes](general-oncology/prognostic-scores/IPSS-Myelodysplastic-Syndromes)
    - [Organ-Specific Prognostic Scores](general-oncology/prognostic-scores/Organ-Specific-Prognostic-Scores)
    - [Disease-Specific Tools](general-oncology/prognostic-scores/Disease-Specific-Tools)
    - [Frailty-Based Prognostication](general-oncology/prognostic-scores/Frailty-Based-Prognostication)
    - [New Biomarker-Integrated Scores](general-oncology/prognostic-scores/New-Biomarker-Integrated-Scores)
    - [Summary Table](general-oncology/prognostic-scores/Summary-Table)
    - [Key Takeaways](general-oncology/prognostic-scores/Key-Takeaways)
    - [References](general-oncology/prognostic-scores/References)
  - Staging Systems
    - [Introduction](general-oncology/staging-systems/Introduction)
    - [TNM Classification (AJCC/UICC)](general-oncology/staging-systems/TNM-Classification)
    - [Clinical (cTNM) vs Pathologic (pTNM) Staging](general-oncology/staging-systems/Clinical-vs-Pathologic-TNM)
    - [TNM by Cancer Type (Summary Table)](general-oncology/staging-systems/TNM-by-Cancer-Type)
    - [Alternative Staging Systems (Ann Arbor, FIGO)](general-oncology/staging-systems/Alternative-Staging-Systems)
    - [Hematologic Cancer Staging (NHL, HL, Leukemia)](general-oncology/staging-systems/Hematologic-Cancer-Staging)
    - [Prefixes and Suffixes in TNM](general-oncology/staging-systems/Prefixes-and-Suffixes-in-TNM)
    - [Staging vs Grading](general-oncology/staging-systems/Staging-vs-Grading)
    - [How Staging Guides Clinical Decision-Making](general-oncology/staging-systems/Clinical-Decision-Making)
    - [Key Takeaways](general-oncology/staging-systems/Key-Takeaways)
    - [References](general-oncology/staging-systems/References)

- Diagnosis & Workup
  - Diagnostic Flow
    - [Introduction](diagnosis-workup/diagnostic-flow/Introduction)
    - [General Diagnostic Algorithm](diagnosis-workup/diagnostic-flow/General-Diagnostic-Algorithm)
    - [Biopsy as the Gold Standard](diagnosis-workup/diagnostic-flow/Biopsy-as-Gold-Standard)
    - [Role of Cytology](diagnosis-workup/diagnostic-flow/Role-of-Cytology)
    - [Initial Laboratory Evaluation](diagnosis-workup/diagnostic-flow/Initial-Laboratory-Evaluation)
    - [Imaging Strategy (Tiered Approach)](diagnosis-workup/diagnostic-flow/Imaging-Strategy)
    - [Liquid Biopsy (ctDNA, CTCs)](diagnosis-workup/diagnostic-flow/Liquid-Biopsy)
    - [Common Diagnostic Pitfalls](diagnosis-workup/diagnostic-flow/Common-Diagnostic-Pitfalls)
    - [Diagnostic Flow Diagram](diagnosis-workup/diagnostic-flow/Diagnostic-Flow-Diagram)
    - [Key Takeaways](diagnosis-workup/diagnostic-flow/Key-Takeaways)
    - [References](diagnosis-workup/diagnostic-flow/References)
  - Histopathology
    - [Introduction](diagnosis-workup/histopathology/Introduction)
    - [Histologic Diagnosis Workflow](diagnosis-workup/histopathology/Histologic-Diagnosis-Workflow)
    - [H&E Staining Basics](diagnosis-workup/histopathology/HE-Staining-Basics)
    - [Tumor Grading](diagnosis-workup/histopathology/Tumor-Grading)
    - [Immunohistochemistry (IHC) and Key Markers](diagnosis-workup/histopathology/Immunohistochemistry-and-Key-Markers)
    - [Special Stains](diagnosis-workup/histopathology/Special-Stains)
    - [Molecular Pathology and Next-Gen Sequencing (NGS)](diagnosis-workup/histopathology/Molecular-Pathology-and-NGS)
    - [Reading and Interpreting Pathology Reports](diagnosis-workup/histopathology/Reading-and-Interpreting-Pathology-Reports)
    - [Red Flags and Clinical Pearls](diagnosis-workup/histopathology/Red-Flags-and-Clinical-Pearls)
    - [Key Takeaways](diagnosis-workup/histopathology/Key-Takeaways)
    - [References](diagnosis-workup/histopathology/References)
  - Radiology
    - [Introduction](diagnosis-workup/radiology/Introduction)
    - [Imaging in Oncology: Role and Principles](diagnosis-workup/radiology/Imaging-in-Oncology)
    - [Imaging Modalities Overview (CT, MRI, PET, US)](diagnosis-workup/radiology/Imaging-Modalities-Overview)
    - [Specialized Imaging Protocols (PET-CT, PET-MRI)](diagnosis-workup/radiology/Specialized-Imaging-Protocols)
    - [Radiologic Signs and Reporting Standards](diagnosis-workup/radiology/Radiologic-Signs-and-Reporting-Standards)
    - [Diagnostic Pitfalls in Imaging](diagnosis-workup/radiology/Diagnostic-Pitfalls-in-Imaging)
    - [Radiology's Role in Treatment Planning](diagnosis-workup/radiology/Radiology-Role-in-Treatment-Planning)
    - [Emerging Imaging Technologies (AI, Radiomics)](diagnosis-workup/radiology/Emerging-Imaging-Technologies)
    - [Key Takeaways](diagnosis-workup/radiology/Key-Takeaways)
    - [References](diagnosis-workup/radiology/References)
  - Tumor Markers
    - [Introduction](diagnosis-workup/tumor-markers/Introduction)
    - [Classification of Tumor Markers](diagnosis-workup/tumor-markers/Classification-of-Tumor-Markers)
    - [Organ-Specific Tumor Markers](diagnosis-workup/tumor-markers/Organ-Specific-Tumor-Markers)
    - [Surveillance vs Diagnosis Roles](diagnosis-workup/tumor-markers/Surveillance-vs-Diagnosis-Roles)
    - [Limitations and Interpretation Pitfalls](diagnosis-workup/tumor-markers/Limitations-and-Interpretation-Pitfalls)
    - [Integration with Imaging and Biopsy](diagnosis-workup/tumor-markers/Integration-with-Imaging-and-Biopsy)
    - [Summary Table](diagnosis-workup/tumor-markers/Summary-Table)
    - [Key Takeaways](diagnosis-workup/tumor-markers/Key-Takeaways)
    - [References](diagnosis-workup/tumor-markers/References)

- Treatment Modalities
  - Chemotherapy
    - [Introduction](treatment-modalities/chemotherapy/Introduction)
    - [Goals of Chemotherapy](treatment-modalities/chemotherapy/Goals-of-Chemotherapy)
    - [Routes of Administration](treatment-modalities/chemotherapy/Routes-of-Administration)
    - [Chemotherapy Agent Classification](treatment-modalities/chemotherapy/Chemotherapy-Agent-Classification)
    - [Common Chemo Regimens by Tumor Type](treatment-modalities/chemotherapy/Common-Chemo-Regimens)
    - [Pharmacokinetics and Pharmacodynamics](treatment-modalities/chemotherapy/Pharmacokinetics-and-Pharmacodynamics)
    - [Dose Modification Principles](treatment-modalities/chemotherapy/Dose-Modification-Principles)
    - [Chemoresistance Mechanisms](treatment-modalities/chemotherapy/Chemoresistance-Mechanisms)
    - [Summary Table](treatment-modalities/chemotherapy/Summary-Table)
    - [Key Takeaways](treatment-modalities/chemotherapy/Key-Takeaways)
    - [References](treatment-modalities/chemotherapy/References)
  - Immunotherapy
    - [Introduction](treatment-modalities/immunotherapy/Introduction)
    - [Major Classes](treatment-modalities/immunotherapy/Major-Classes)
    - [Immune Checkpoint Inhibitors](treatment-modalities/immunotherapy/Immune-Checkpoint-Inhibitors)
    - [Biomarkers (PD-L1, TMB, MSI-H)](treatment-modalities/immunotherapy/Biomarkers)
    - [CAR-T Cell Therapy](treatment-modalities/immunotherapy/CAR-T-Cell-Therapy)
    - [Emerging Immunotherapies](treatment-modalities/immunotherapy/Emerging-Immunotherapies)
    - [Immune-Related Adverse Events (irAEs)](treatment-modalities/immunotherapy/Immune-Related-Adverse-Events)
    - [Management of irAEs](treatment-modalities/immunotherapy/Management-of-irAEs)
    - [Key Takeaways](treatment-modalities/immunotherapy/Key-Takeaways)
    - [References](treatment-modalities/immunotherapy/References)
  - Radiotherapy
    - [Introduction](treatment-modalities/radiotherapy/Introduction)
    - [Mechanisms of Radiation-Induced Cancer Control](treatment-modalities/radiotherapy/Mechanisms-of-Radiation-Induced-Cancer-Control)
    - [Types of Radiotherapy (EBRT, Brachytherapy, SRS)](treatment-modalities/radiotherapy/Types-of-Radiotherapy)
    - [Indications by Intent](treatment-modalities/radiotherapy/Indications-by-Intent)
    - [Radiation Planning](treatment-modalities/radiotherapy/Radiation-Planning)
    - [Radiosensitizers and Radioprotectants](treatment-modalities/radiotherapy/Radiosensitizers-and-Radioprotectants)
    - [Acute and Chronic Radiation Toxicities](treatment-modalities/radiotherapy/Acute-and-Chronic-Radiation-Toxicities)
    - [Radiotherapy in Special Populations](treatment-modalities/radiotherapy/Radiotherapy-in-Special-Populations)
    - [Key Takeaways](treatment-modalities/radiotherapy/Key-Takeaways)
    - [References](treatment-modalities/radiotherapy/References)
  - Surgery
    - [Introduction](treatment-modalities/surgery/Introduction)
    - [Principles of Surgical Oncology](treatment-modalities/surgery/Principles-of-Surgical-Oncology)
    - [Resection Margins and Their Significance](treatment-modalities/surgery/Resection-Margins)
    - [Minimally Invasive and Robotic Surgery](treatment-modalities/surgery/Minimally-Invasive-and-Robotic-Surgery)
    - [Surgery in Multimodal Settings](treatment-modalities/surgery/Surgery-in-Multimodal-Settings)
    - [Decision-Making on Resectability](treatment-modalities/surgery/Decision-Making-on-Resectability)
    - [Post-Surgical Complications](treatment-modalities/surgery/Post-Surgical-Complications)
    - [Clinical Pearls for Surgical Oncology](treatment-modalities/surgery/Clinical-Pearls-for-Surgical-Oncology)
    - [Key Takeaways](treatment-modalities/surgery/Key-Takeaways)
    - [References](treatment-modalities/surgery/References)
  - Targeted Therapy
    - [Introduction](treatment-modalities/targeted-therapy/Introduction)
    - [Mechanisms](treatment-modalities/targeted-therapy/Mechanisms)
    - [Key Targetable Alterations and Matching Drugs](treatment-modalities/targeted-therapy/Key-Targetable-Alterations)
    - [Biomarker Testing Workflow](treatment-modalities/targeted-therapy/Biomarker-Testing-Workflow)
    - [Resistance Mechanisms](treatment-modalities/targeted-therapy/Resistance-Mechanisms)
    - [Common Toxicities (Class-Specific)](treatment-modalities/targeted-therapy/Common-Toxicities)
    - [Tissue-Agnostic Approvals](treatment-modalities/targeted-therapy/Tissue-Agnostic-Approvals)
    - [Key Clinical Pearls](treatment-modalities/targeted-therapy/Key-Clinical-Pearls)
    - [Key Takeaways](treatment-modalities/targeted-therapy/Key-Takeaways)
    - [References](treatment-modalities/targeted-therapy/References)
- Systems Oncology
  - Breast Cancer
    - [Overview](systems-oncology/breast-cancer/Overview)
    - [Epidemiology and Risk Factors](systems-oncology/breast-cancer/Epidemiology-and-Risk-Factors)
    - [Histologic and Molecular Subtypes](systems-oncology/breast-cancer/Histologic-and-Molecular-Subtypes)
    - [Diagnostic Workup (Imaging, Biopsy)](systems-oncology/breast-cancer/Diagnostic-Workup)
    - [Staging (AJCC 8th Edition)](systems-oncology/breast-cancer/Staging-AJCC-8th-Edition)
    - [Treatment by Stage](systems-oncology/breast-cancer/Treatment-by-Stage)
    - [Surgery (BCS, Mastectomy)](systems-oncology/breast-cancer/Surgery)
    - [Radiation Therapy Indications](systems-oncology/breast-cancer/Radiation-Therapy-Indications)
    - [Systemic Therapy: Hormone, HER2+, TNBC](systems-oncology/breast-cancer/Systemic-Therapy)
    - [Neoadjuvant vs Adjuvant Approaches](systems-oncology/breast-cancer/Neoadjuvant-vs-Adjuvant)
    - [Metastatic Breast Cancer](systems-oncology/breast-cancer/Metastatic-Breast-Cancer)
    - [Survivorship and Surveillance](systems-oncology/breast-cancer/Survivorship-and-Surveillance)
    - [Prevention and Screening Strategies](systems-oncology/breast-cancer/Prevention-and-Screening-Strategies)
    - [Key Takeaways](systems-oncology/breast-cancer/Key-Takeaways)
    - [References](systems-oncology/breast-cancer/References)
  
  - Colorectal Cancer
    - [Overview](systems-oncology/colorectal-cancer/Overview)
    - [Risk Factors and Genetic Syndromes](systems-oncology/colorectal-cancer/Risk-Factors-and-Genetic-Syndromes)
    - [Common Molecular Pathways](systems-oncology/colorectal-cancer/Common-Molecular-Pathways)
    - [Symptoms and Clinical Presentation](systems-oncology/colorectal-cancer/Symptoms-and-Clinical-Presentation)
    - [Diagnostic Workup (Colonoscopy, Imaging)](systems-oncology/colorectal-cancer/Diagnostic-Workup)
    - [Staging (AJCC 8th Edition)](systems-oncology/colorectal-cancer/Staging-AJCC-8th-Edition)
    - [Treatment Approach: Colon vs Rectal Cancer](systems-oncology/colorectal-cancer/Treatment-Approach)
    - [Metastatic Disease and Oligometastatic Management](systems-oncology/colorectal-cancer/Metastatic-and-Oligometastatic-Management)
    - [Surveillance and Recurrence Risk](systems-oncology/colorectal-cancer/Surveillance-and-Recurrence-Risk)
    - [Key Takeaways](systems-oncology/colorectal-cancer/Key-Takeaways)
    - [References](systems-oncology/colorectal-cancer/References)
  
  - Lung Cancer
    - [Overview](systems-oncology/lung-cancer/Overview)
    - [Risk Factors (Smoking, Radon, Asbestos)](systems-oncology/lung-cancer/Risk-Factors)
    - [NSCLC Subtypes vs Small Cell Lung Cancer](systems-oncology/lung-cancer/NSCLC-vs-SCLC)
    - [Paraneoplastic Syndromes](systems-oncology/lung-cancer/Paraneoplastic-Syndromes)
    - [Diagnostic Approach](systems-oncology/lung-cancer/Diagnostic-Approach)
    - [Staging (AJCC 8th Edition)](systems-oncology/lung-cancer/Staging-AJCC-8th-Edition)
    - [NSCLC: Surgical, Radiotherapy, Systemic Treatments](systems-oncology/lung-cancer/NSCLC-Treatment)
    - [SCLC: Limited vs Extensive Stage](systems-oncology/lung-cancer/SCLC-Treatment)
    - [Radiation Therapy Role (SBRT, PCI)](systems-oncology/lung-cancer/Radiation-Therapy-Role)
    - [Resectability and Multidisciplinary Planning](systems-oncology/lung-cancer/Resectability-and-Multidisciplinary-Planning)
    - [Surveillance and Survivorship](systems-oncology/lung-cancer/Surveillance-and-Survivorship)
    - [Key Takeaways](systems-oncology/lung-cancer/Key-Takeaways)
    - [References](systems-oncology/lung-cancer/References)
  
  - Head & Neck Cancer
    - [Overview](systems-oncology/head-neck-cancer/Overview)
    - [Risk Factors (Tobacco, HPV)](systems-oncology/head-neck-cancer/Risk-Factors)
    - [Common Presentations](systems-oncology/head-neck-cancer/Common-Presentations)
    - [Diagnostic Workup and Imaging](systems-oncology/head-neck-cancer/Diagnostic-Workup-and-Imaging)
    - [Staging (AJCC 8th Edition)](systems-oncology/head-neck-cancer/Staging-AJCC-8th-Edition)
    - [Treatment by Subsite and Stage](systems-oncology/head-neck-cancer/Treatment-by-Subsite-and-Stage)
    - [Systemic Therapy Principles](systems-oncology/head-neck-cancer/Systemic-Therapy-Principles)
    - [Complications and Supportive Care](systems-oncology/head-neck-cancer/Complications-and-Supportive-Care)
    - [Key Takeaways](systems-oncology/head-neck-cancer/Key-Takeaways)
    - [References](systems-oncology/head-neck-cancer/References)

  - Prostate Cancer
    - [Overview](systems-oncology/prostate-cancer/Overview)
    - [Risk Factors (Age, Race, Genetics)](systems-oncology/prostate-cancer/Risk-Factors)
    - [Diagnostic Evaluation (PSA, Biopsy, MRI)](systems-oncology/prostate-cancer/Diagnostic-Evaluation)
    - [Risk Stratification (NCCN Guidelines)](systems-oncology/prostate-cancer/Risk-Stratification)
    - [Localized Disease Management](systems-oncology/prostate-cancer/Localized-Disease-Management)
    - [Androgen Deprivation Therapy (ADT)](systems-oncology/prostate-cancer/Androgen-Deprivation-Therapy)
    - [Metastatic Prostate Cancer (mHSPC, mCRPC)](systems-oncology/prostate-cancer/Metastatic-Prostate-Cancer)
    - [Surveillance and Monitoring](systems-oncology/prostate-cancer/Surveillance-and-Monitoring)
    - [Key Takeaways](systems-oncology/prostate-cancer/Key-Takeaways)
    - [References](systems-oncology/prostate-cancer/References)
  - Lymphomas
    - [Overview](systems-oncology/lymphomas/Overview)
    - [Classification (HL vs NHL)](systems-oncology/lymphomas/Classification)
    - [Diagnostic Workup and Immunophenotyping](systems-oncology/lymphomas/Diagnostic-Workup-and-Immunophenotyping)
    - [Staging – Ann Arbor System](systems-oncology/lymphomas/Staging-Ann-Arbor-System)
    - [Treatment of Hodgkin Lymphoma](systems-oncology/lymphomas/Treatment-of-Hodgkin-Lymphoma)
    - [Non-Hodgkin Lymphoma Approaches](systems-oncology/lymphomas/Non-Hodgkin-Lymphoma-Approaches)
    - [CNS Prophylaxis Indications](systems-oncology/lymphomas/CNS-Prophylaxis-Indications)
    - [Management of Relapsed/Refractory Disease](systems-oncology/lymphomas/Management-of-Relapsed-Refractory-Disease)
    - [Surveillance Strategies](systems-oncology/lymphomas/Surveillance-Strategies)
    - [Key Takeaways](systems-oncology/lymphomas/Key-Takeaways)
    - [References](systems-oncology/lymphomas/References)

  - Leukemias
    - [Overview](systems-oncology/leukemias/Overview)
    - [Clinical Features and Diagnosis](systems-oncology/leukemias/Clinical-Features-and-Diagnosis)
    - [AML – Approach to Diagnosis and Treatment](systems-oncology/leukemias/AML-Approach-to-Diagnosis-and-Treatment)
    - [APL – Emergency Recognition (ATRA Therapy)](systems-oncology/leukemias/APL-Emergency-Recognition-ATRA-Therapy)
    - [ALL – Risk Stratification and Management](systems-oncology/leukemias/ALL-Risk-Stratification-and-Management)
    - [CML – TKIs and Resistance Mechanisms](systems-oncology/leukemias/CML-TKIs-and-Resistance-Mechanisms)
    - [CLL – Indolent vs High-Risk Disease](systems-oncology/leukemias/CLL-Indolent-vs-High-Risk-Disease)
    - [Leukemia Emergencies (TLS, Leukostasis, DIC)](systems-oncology/leukemias/Leukemia-Emergencies)
    - [Key Takeaways](systems-oncology/leukemias/Key-Takeaways)
    - [References](systems-oncology/leukemias/References)
  - Gastrointestinal Cancers
    - [Overview](systems-oncology/gastrointestinal-cancers/Overview)
    - [Esophageal and GEJ Cancer](systems-oncology/gastrointestinal-cancers/Esophageal-and-GEJ-Cancer)
    - [Gastric Cancer](systems-oncology/gastrointestinal-cancers/Gastric-Cancer)
    - [Hepatocellular Carcinoma (HCC)](systems-oncology/gastrointestinal-cancers/Hepatocellular-Carcinoma-HCC)
    - [Cholangiocarcinoma and Gallbladder Cancer](systems-oncology/gastrointestinal-cancers/Cholangiocarcinoma-and-Gallbladder-Cancer)
    - [Pancreatic Cancer](systems-oncology/gastrointestinal-cancers/Pancreatic-Cancer)
    - [Key Takeaways](systems-oncology/gastrointestinal-cancers/Key-Takeaways)
    - [References](systems-oncology/gastrointestinal-cancers/References)

  - Gynecologic Cancers
    - [Overview](systems-oncology/gynecologic-cancers/Overview)
    - [Ovarian Cancer](systems-oncology/gynecologic-cancers/Ovarian-Cancer)
    - [Endometrial Cancer](systems-oncology/gynecologic-cancers/Endometrial-Cancer)
    - [Cervical Cancer](systems-oncology/gynecologic-cancers/Cervical-Cancer)
    - [Vulvar and Vaginal Cancer (Quick Reference)](systems-oncology/gynecologic-cancers/Vulvar-and-Vaginal-Cancer-Quick-Reference)
    - [Screening and Prevention Strategies](systems-oncology/gynecologic-cancers/Screening-and-Prevention-Strategies)
    - [Key Takeaways](systems-oncology/gynecologic-cancers/Key-Takeaways)
    - [References](systems-oncology/gynecologic-cancers/References)

  - Urological Cancers
    - [Overview](systems-oncology/urological-cancers/Overview)
    - [Bladder Cancer (NMIBC vs MIBC)](systems-oncology/urological-cancers/Bladder-Cancer-NMIBC-vs-MIBC)
    - [Renal Cell Carcinoma (RCC)](systems-oncology/urological-cancers/Renal-Cell-Carcinoma-RCC)
    - [Testicular Cancer (Seminoma vs NSGCT)](systems-oncology/urological-cancers/Testicular-Cancer-Seminoma-vs-NSGCT)
    - [Surveillance and Follow-Up](systems-oncology/urological-cancers/Surveillance-and-Follow-Up)
    - [Summary Table](systems-oncology/urological-cancers/Summary-Table)
    - [Key Takeaways](systems-oncology/urological-cancers/Key-Takeaways)
    - [References](systems-oncology/urological-cancers/References)
  - CNS Tumors
    - [Overview](systems-oncology/cns-tumors/Overview)
    - [Gliomas (WHO Classification)](systems-oncology/cns-tumors/Gliomas-WHO-Classification)
    - [Meningiomas](systems-oncology/cns-tumors/Meningiomas)
    - [Medulloblastomas](systems-oncology/cns-tumors/Medulloblastomas)
    - [Brain Metastases](systems-oncology/cns-tumors/Brain-Metastases)
    - [Leptomeningeal Disease (LMD)](systems-oncology/cns-tumors/Leptomeningeal-Disease-LMD)
    - [Radiation Modalities in Neuro-Oncology](systems-oncology/cns-tumors/Radiation-Modalities-in-Neuro-Oncology)
    - [Key Takeaways](systems-oncology/cns-tumors/Key-Takeaways)
    - [References](systems-oncology/cns-tumors/References)

  - Pediatric Oncology (Core Topics)
    - [Overview](systems-oncology/pediatric-oncology/Overview)
    - [Neuroblastoma](systems-oncology/pediatric-oncology/Neuroblastoma)
    - [Wilms Tumor](systems-oncology/pediatric-oncology/Wilms-Tumor)
    - [Rhabdomyosarcoma](systems-oncology/pediatric-oncology/Rhabdomyosarcoma)
    - [Pediatric-Specific Considerations](systems-oncology/pediatric-oncology/Pediatric-Specific-Considerations)
    - [Key Takeaways](systems-oncology/pediatric-oncology/Key-Takeaways)
    - [References](systems-oncology/pediatric-oncology/References)
- Toxicities
  - Acute & Chronic Toxicities
    - [Overview](toxicities/acute-and-chronic-toxicities/Overview)
    - [Acute Toxicity Management](toxicities/acute-and-chronic-toxicities/Acute-Toxicity-Management)
    - [Chronic Toxicity Monitoring](toxicities/acute-and-chronic-toxicities/Chronic-Toxicity-Monitoring)
    - [Long-Term Survivorship Planning](toxicities/acute-and-chronic-toxicities/Long-Term-Survivorship-Planning)
    - [Organ-Specific Late Effects](toxicities/acute-and-chronic-toxicities/Organ-Specific-Late-Effects)
    - [CTCAE (Common Terminology Criteria for Adverse Events)](toxicities/acute-and-chronic-toxicities/CTCAE-Common-Terminology-Criteria-for-Adverse-Events)
    - [Application in Clinical Trials](toxicities/acute-and-chronic-toxicities/Application-in-Clinical-Trials)

  - Chemo-Specific Toxicities
    - [Class-Specific Side Effects](toxicities/chemo-specific-toxicities/Class-Specific-Side-Effects)
    - [Neurotoxicity, Cardiotoxicity, Pulmonary Toxicity](toxicities/chemo-specific-toxicities/Neurotoxicity-Cardiotoxicity-Pulmonary-Toxicity)
    - [Summary Tables of Common Toxicities](toxicities/chemo-specific-toxicities/Summary-Tables-of-Common-Toxicities)
    - [Preventive Strategies](toxicities/chemo-specific-toxicities/Preventive-Strategies)

  - Survivorship
    - [Key Domains](toxicities/survivorship/Key-Domains)
    - [Fertility, Psychosocial Health, Second Malignancies](toxicities/survivorship/Fertility-Psychosocial-Health-Second-Malignancies)
    - [Surveillance After Curative Therapy](toxicities/survivorship/Surveillance-After-Curative-Therapy)
    - [Survivorship Care Plans (SCPs)](toxicities/survivorship/Survivorship-Care-Plans-SCPs)
- Supportive Care
  - [Antiemetics (Nausea and Vomiting Management)](supportive-care/Antiemetics-Nausea-and-Vomiting-Management)
  - [G-CSF Use (Prevention of Neutropenia)](supportive-care/G-CSF-Use-Prevention-of-Neutropenia)
  - [Pain Management (WHO Ladder, Neuropathic Pain)](supportive-care/Pain-Management-WHO-Ladder-Neuropathic-Pain)
  - [Nutrition in Oncology (Malnutrition, Cachexia)](supportive-care/Nutrition-in-Oncology-Malnutrition-Cachexia)
  - [Palliative Care Principles (Early vs Late)](supportive-care/Palliative-Care-Principles-Early-vs-Late)
  - [Ethical and Cultural Considerations in Palliative Care](supportive-care/Ethical-and-Cultural-Considerations-in-Palliative-Care)
- Oncologic Emergencies
  - [Tumor Lysis Syndrome (TLS)](oncologic-emergencies/Tumor-Lysis-Syndrome-TLS)
  - [Spinal Cord Compression](oncologic-emergencies/Spinal-Cord-Compression)
  - [Hypercalcemia of Malignancy](oncologic-emergencies/Hypercalcemia-of-Malignancy)
  - [Febrile Neutropenia](oncologic-emergencies/Febrile-Neutropenia)
  - [Superior Vena Cava Syndrome (SVCS)](oncologic-emergencies/Superior-Vena-Cava-Syndrome-SVCS)
  - [Uterine Fibroids](oncologic-emergencies/Uterine-Fibroids)
  - [Cancer-Related Fatigue](oncologic-emergencies/Cancer-Related-Fatigue)
  - [Key Takeaways](oncologic-emergencies/Key-Takeaways)
  - [References](oncologic-emergencies/References)
- Special Topics
  - [Cancer in Pregnancy](special-topics/Cancer-in-Pregnancy)
  - [Geriatric Oncology (Elderly Populations)](special-topics/Geriatric-Oncology-Elderly-Populations)
  - [Fertility Preservation](special-topics/Fertility-Preservation)
  - [Cancer Genetics and Hereditary Syndromes](special-topics/Cancer-Genetics-and-Hereditary-Syndromes)
  - [Oncology in Immunocompromised Hosts](special-topics/Oncology-in-Immunocompromised-Hosts)
- Resources and Tools
  - [Oncology Calculators (BSA, CrCl, FN Risk, Prognostic Indices)](resources-and-tools/Oncology-Calculators-BSA-CrCl-FN-Risk-Prognostic-Indices)
  - [Radiation Tools (EQD2, BED)](resources-and-tools/Radiation-Tools-EQD2-BED)
  - [Quick Reference Guidelines (Summary Tables)](resources-and-tools/Quick-Reference-Guidelines-Summary-Tables)
  - [Downloadable Cheat Sheets and Checklists](resources-and-tools/Downloadable-Cheat-Sheets-and-Checklists)
  - [Key Organizations (NCCN, ASCO, ESMO, etc.)](resources-and-tools/Key-Organizations-NCCN-ASCO-ESMO)
